Skip to content

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists - Research of health-related QOL with EQ-5D-5L using a web application by community pharmacists

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041942
Enrollment
5000
Registered
2020-09-30
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All diseases

Interventions

None listed

Sponsors

School of Nursing and Rehabilitation Sciences, Showa University
Lead Sponsor
(1)QOL Co., Ltd. (2)Nihon Chouzai Co., Ltd. (3)KRAFT Inc. (4)SOGO MEDICAL CO., LTD (5)AIN PHARMACIEZ INC. (6)Study group for Comprehensive Cost-Effectiveness Analysis of Pharmacotherapy
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients who are 20 years old or more at the time of consent acquisition. (2) Patients provided written informed consent (3)Patients who have been issued prescriptions by medical institutions

Exclusion criteria

Exclusion criteria: (1)Requested for cancellation from patients (2)Interrupted due to the circumstances of the research patients (moving, changing doctor / hospital, busy, unfollowable) (3)Judged that evaluation is not possible due to serious deviation from protocol (4)Patients judged inappropriate in this study

Design outcomes

Primary

MeasureTime frame
An observation period of 6 months or more will be provided from the start of registration. Health-related QOL is measured 4 or more times during the observation period. The primary endpoint is quality-adjusted life years (QALY).

Secondary

MeasureTime frame
Adverse event

Countries

Japan

Contacts

Public ContactHayato Murata

Qol Co., Ltd. Kanto Pharmacy Headquarter 1

hayato-m@pharm.showa-u.ac.jp045-949-5800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026